Decision making in juvenile myoclonic epilepsy

Journal of Neurology

Volumn 260, Issue 3, 2013, Pages 839-846

  Zamarian, Laura ^a   Höfler, Julia ^a,b   Kuchukhidze, Giorgi ^a   Delazer, Margarete ^a   Bonatti, Elisabeth ^a   Kemmler, Georg ^a   Trinka, Eugen ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Decision making; Executive functions; Idiopathic generalized epilepsy; Juvenile myoclonic epilepsy; Neuropsychology

Indexed keywords

ETIRACETAM; LAMOTRIGINE; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; AMBIGUITY; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MYOCLONUS EPILEPSY; NEUROPSYCHOLOGY; PATIENT DECISION MAKING; PRIORITY JOURNAL; SEIZURE; WORKING MEMORY;

ADOLESCENT; ADULT; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCLONIC EPILEPSY, JUVENILE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 84876485457     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6715-z     Document Type: Article

References (44)

1. Commission on Classification and Terminology of the International League against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399
2. Janz D, Christian W (1957) Impulsiv-petit mal. Deutsche Zeitschrift für. Nervenheilkunde 176:346-386
3. Trinka E, Kienpointner G, Unterberger I, Luef G, Bauer G, Doering LB, Doering S (2006) Psychiatric comorbidity in juvenile myoclonic epilepsy. Epilepsia 47:2086-2091
4. Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C (2001) Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 70:240-243
5. Devinsky O, Gershengorn J, Brown E, Perrine K, Vazquez B, Luciano D (1997) Frontal functions in juvenile myoclonic epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 10:243-246
6. Kim SY, Hwang YH, Lee HW, Suh CK, Kwon SH, Park SP (2007) Cognitive impairment in juvenile myoclonic epilepsy. J Clin Neurol 3:86-92
7. Piazzini A, Turner K, Vignoli A, Canger R, Canevini MP (2008) Frontal cognitive dysfunction in juvenile myoclonic epilepsy. Epilepsia 49:657-662
8. Schwartz BE, Halgren E, Simpkins F, Syndulko K (1994) Memory in patients with frontal and primary generalized epilepsy. J Epilepsy 7:232-241
9. de Araujo Filho GM, Jackowski AP, Lin K, Peruchi MM, Cabocio LO, Guaranha MS, Guilhoto LM, Carrete H Jr, Yacubian EM (2009) Personality traits related to juvenile myoclonic epilepsy: MRI reveals prefrontal abnormalities through a voxel-based morphometry study. Epilepsy Behav 15:202-207
10. Savic I, Lekvall A, Greitz D, Helms G (2000) MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy. Epilepsia 41:290-296
11. Holmes MD, Quiring J, Tucker DM (2010) Evidence that juvenile myoclonic epilepsy is a disorder of frontotemporal corticothalamic networks. Neuroimage 49:80-93
12. Ciumas C, Wahlin TB, Jucaite A, Lindstrom P, Halldin C, Savic I (2008) Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy. Neurology 71:788-794
13. Vollmar C, O'Muircheartaigh J, Barker GJ, Symms MR, Thompson P, Kumari V, Duncan JS, Janz D, Richardson MP, Kopp MJ (2011) Motor system hyperconnectivity in juvenile myoclonic epilepsy: a cognitive functional magnetic resonance imaging study. Brain 134:1710-1719
14. Vollmar C, O'Muircheartaigh J, Symms MR, Barker GJ, Thompson P, Kumari V, Stretton J, Duncan JS, Richardson MP, Koepp MJ (2012) Altered microstructural connectivity in juvenile myoclonic epilepsy: the missing link. Neurology 78:1555-1559
15. Ronan L, Alhusaini S, Scanlon C, Doherty CP, Delanty N, Fitzsimons M (2012) Widespread cortical morphologic changes in juvenile myoclonic epilepsy: evidence from structural MRI. Epilepsia 53:651-658
16. Trepel C, Fox CR, Poldrack RA (2005) Prospect theory on the brain? Toward a cognitive neuroscience of decision under risk. Brain Res Cogn Brain Res 23:34-50
17. Gleichgerrcht E, Ibanez A, Roca M, Torralva T, Manes F (2010) Decision-making cognition in neurodegenerative diseases. Nat Rev Neurol 6:611-623
18. Schultz W, Preuschoff K, Camerer C, Hsu M, Fiorillo CD, Tobler PN, Bossaerts P (2008) Explicit neural signals reflecting reward uncertainty. Philos Trans R Soc Lond B Biol Sci 363:3801-3811
19. Bechara A, Damasio H, Damasio AR (2000) Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 10:295-307
20. Dunn BD, Dalgleish T, Lawrence AD (2006) The somatic marker hypothesis: a critical evaluation. Neurosci Biobehav Rev 30:239-271
21. Härting C, Markowitsch HJ, Neufeld H, Calabrese P, Deisinger K, Kessler J (2000) WMS-R Wechsler Gedächtnistest-Revidierte Fassung. Hans Huber, Bern
22. Lezak MD (1998) Neuropsychological assessment. Oxford University Press, New York
23. Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeits-Test (RWT). Hogrefe, Göttingen
24. Kohler J, Beck U (2000) Planungstest. Beck and Kohler GbR, Kostanz
25. Kongs SK, Thompson LL, Iverson GL, Heaton RK (2000) The Wisconsin card sorting test (WCST-64). Hogrefe Testzentrale, Göttingen
26. Lehrl S (1991) Manual zum MWT-B. Spitta, Balingen
27. Brand M, Labudda K, Markowitsch HJ (2006) Neuropsychological correlates of decision-making in ambiguous and risky situations. Neural Netw 19:1266-1276
28. Zamarian L, Sinz H, Bonatti E, Gamboz N, Delazer M (2008) Normal aging affects decisions under ambiguity, but not decisions under risk. Neuropsychology 22:645-657
29. Brand M, Markowitsch HJ (2010) Aging and decision-making: a neurocognitive perspective. Gerontology 56:319-324
30. Delazer M, Zamarian L, Bonatti E, Kuchukhidze G, Koppelstätter F, Bodner T, Benke T, Trinka E (2010) Decision making under ambiguity and under risk in mesial temporal lobe epilepsy. Neuropsychologia 48:194-200
31. Zamarian L, Trinka E, Bonatti E, Kuchukhidze G, Bodner T, Benke T, Koppelstaetter F, Delazer M (2011) Executive functions in chronic mesial temporal lobe epilepsy. Epilepsy Res Treat. doi: 10.1155/2011/596174
32. Brand M, Recknor EC, Grabenhorst F, Bechara A (2007) Decisions under ambiguity and decisions under risk: correlations with executive functions and comparisons of two different gambling tasks with implicit and explicit rules. J Clin Exp Neuropsychol 29:86-99
33. Bar-On R, Tranel D, Denburg NL, Bechara A (2003) Exploring the neurological substrate of emotional and social intelligence. Brain 126:1790-1800
34. Brand M, Grabenhorst F, Starcke K, Vandekerckehove MM, Markowitsch HJ (2007) Role of the amygdala in decisions under ambiguity and decisions under risk: evidence from patients with Urbach-Wiethe disease. Neuropsychologia 45:1305-1317
35. Cools R, Barker RA, Sahakian BJ, Robbins TW (2003) l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 41:1431-1441
36. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381
37. Mega MS, Cummings JL (1994) Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 6:358-370
38. Bouilleret V, Semah F, Biraben A, Taussig D, Chassoux F, Syrota A, Ribeiro MJ (2005) Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-l-DOPA PET study using 2 methods of analysis. J Nucl Med 46:540-547
39. Owen AM (2004) Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 10:525-537
40. Meador KJ (2006) Cognitive and memory effects of the new antiepileptic drugs. Epilepsy Res 68:63-67
41. Cavanna AE, Ali F, Rickards HE, McCorry D (2010) Behavioral and cognitive effects of anti-epileptic drugs. Discov Med 9:138-144
42. Aldenkamp AP, DeKrom M, Reijs R (2003) Newer antiepileptic drugs and cognitive issues. Epilepsia 44(Suppl 4):21-29
43. Loring DW, Marino S, Meador KJ (2007) Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 17:413-425
44. Mantoan L, Walker M (2011) Treatment options in juvenile myoclonic epilepsy. Curr Treat Options Neurol 13:355-370